Skip to main content

AICAR

No sources yet

An index of captured practitioner sources, not a completed evidence summary. Unchecked figures and empty sections are omitted. See the library review status.

Source summary generated November 6, 2026; this date does not indicate completed review.

Mitochondrial & EnergyAliases: acadesine, AICA riboside, 5-aminoimidazole-4-carboxamide ribonucleoside
Track your own protocol free →

Quotes from three independent practitioners, with their sources. Research context only.

What it is and how it works

From the published literature on AICAR; the papers are listed at the end. Research summary, not a recommendation.

What it is

AICAR (5-aminoimidazole-4-carboxamide ribonucleoside, also called acadesine or AICA riboside) is a small nucleoside, not a peptide. It is a close relative of a compound the body makes while building purines (the DNA and RNA building blocks), and once inside cells it is converted to a form that mimics AMP, the cell's low-energy signal. It has been used for decades as a laboratory tool and was tested as a drug under the name acadesine.

How it works

The AMP-mimicking form switches on AMPK (AMP-activated protein kinase), an enzyme that acts as a cell's energy sensor and, when activated, increases glucose uptake and shifts muscle toward burning fat. In sedentary mice, four weeks of AICAR increased running endurance and switched on muscle genes also driven by training, which is why it was called an exercise mimetic. A systematic review cautioned that many AICAR effects once credited to AMPK turned out to be AMPK-independent, so results from AICAR experiments do not map cleanly onto AMPK biology.

What it has been studied for

  • Muscle glucose uptake in healthy men (small controlled human study)
  • Protection of the heart during coronary artery bypass surgery (randomized trial of acadesine)
  • Endurance and muscle metabolism as an exercise mimetic (mouse study)
  • Muscle pathology in a mouse model of spinal muscular atrophy (mouse study)

Strength of the evidence

Human trialsAcadesine was tested in randomized multicenter trials in cardiac surgery with mixed results and in a controlled study of muscle glucose uptake in healthy men, but the exercise-mimetic claims rest mainly on mouse data.

What the literature reports on safety

AICAR is not an FDA-approved medicine, and it is not named on the FDA compounding-substances page (content current as of 2026-04-22). The cardiac-surgery trial reported a reduction in one heart-attack subtype only in a high-risk subgroup and no significant effect overall. Published copies of the 2026 World Anti-Doping Agency Prohibited List name AICAR as an example of the prohibited AMPK activators (section S4.4.1).

Key papers

  1. AICAr, a Widely Used AMPK Activator with Important AMPK-Independent Effects: A Systematic Review. (opens in a new tab)

    Review · Višnjić D, Lalić H, et al. · Cells (2021) · PMID 34064363

    Found a growing number of studies showing that many AICAR effects once attributed to AMPK activation are AMPK-independent, and called for caution interpreting AICAR-based work.

  2. AMPK and PPARdelta agonists are exercise mimetics. (opens in a new tab)

    Animal study · Narkar VA, Downes M, et al. · Cell (2008) · PMID 18674809

    In sedentary mice, four weeks of AICAR alone induced muscle metabolic genes and raised running endurance by 44%.

  3. Can exercise mimetics substitute for exercise? (opens in a new tab)

    Review · Richter EA, Kiens B, et al. · Cell Metabolism (2008) · PMID 18680710

    Commented that drug treatment and genetic manipulation in mice mimicked many exercise-induced muscle adaptations, raising the question of whether such drugs could stand in for exercise in people.

  4. 5-aminoimidazole-4-carboxamide 1-beta-D-ribofuranoside acutely stimulates skeletal muscle 2-deoxyglucose uptake in healthy men. (opens in a new tab)

    Cohort study · Cuthbertson DJ, Babraj JA, et al. · Diabetes (2007) · PMID 17513706

    In 29 healthy men, AICAR raised muscle glucose uptake about two-fold, compared with about five-fold for bicycle exercise.

  5. Acadesine: a new drug that may improve myocardial protection in coronary artery bypass grafting. Results of the first international multicenter study. (opens in a new tab)

    Randomized trial · Menasché P, Jamieson WR, et al. · Journal of Thoracic and Cardiovascular Surgery (1995) · PMID 7475138

    In 821 bypass patients randomized to acadesine or placebo, acadesine did not significantly change the overall heart-attack rate but reduced Q-wave heart attacks in the high-risk group.

  6. Chronic Treatment with the AMPK Agonist AICAR Prevents Skeletal Muscle Pathology but Fails to Improve Clinical Outcome in a Mouse Model of Severe Spinal Muscular Atrophy. (opens in a new tab)

    Animal study · Cerveró C, Montull N, et al. · Neurotherapeutics (2016) · PMID 26582176

    Long-term AICAR prevented muscle damage in a mouse model of spinal muscular atrophy but did not improve the animals' clinical outcome.

Sources checked: PubMed (E-utilities abstracts for every PMID), FDA compounding-substances page (current as of 2026-04-22), published copies of the WADA 2026 Prohibited List (via search; official PDF text not machine-readable), written 2026-11-06.

No sources yet

None of the three teachers' sources we have indexed discuss AICAR yet. This page will fill in as sources are added.

Deeper guided audio lives on What Am I Appreciating Now (leaves this site, opens in a new tab). What Am I Appreciating Now is a separate site run by the same operator; it sells meditation and hypnosis sessions.

Disclaimer: for research purposes only

All content on this page is for research and educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before starting any peptide or hormone protocol. You take responsibility for your own protocol.If your path includes peptides, you buy them yourself from an independent licensed provider through a member co-op; we take nothing. How independent access works.

AICAR — Hunter, Taylor, Bachmeyer | Reset Biology